The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice
The purpose of the programme is to collect safety data on ambrisentan when used in clinical practice
Study Type
OBSERVATIONAL
Enrollment
800
ambrisentan
safety monitoring
safety monitoring
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
GSK Investigational Site
Darlinghurst, New South Wales, Australia
GSK Investigational Site
Chermside, Queensland, Australia
GSK Investigational Site
Melbourne, Victoria, Australia
GSK Investigational Site
Brussels, Belgium
GSK Investigational Site
Leuven, Belgium
GSK Investigational Site
Edmonton, Alberta, Canada
GSK Investigational Site
Vancouver, British Columbia, Canada
GSK Investigational Site
Winnipeg, Manitoba, Canada
GSK Investigational Site
Halifax, Nova Scotia, Canada
GSK Investigational Site
London, Ontario, Canada
...and 102 more locations